Cite
HARVARD Citation
Sahebnasagh, A. et al. (2020). Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID‐19. Journal of clinical pharmacy and therapeutics. pp. 1515-1519. [Online].